Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be repurchased at a price not more than CNY 11.85 per share.

The repurchased shares will be used for ESOP or equity incentives. The authorization will be valid for a period of 6 months.